The authors proposed that increased cMyBP-C phosphorylation is an early indicator of HFpEF and diastolic dysfunction in diabetic cardiomyopathy, and that cMyBP-C hyperphosphorylation may be linked to the pathogenesis of this condition. This evidence concerns the gene MYBPC3 and diabetic cardiomyopathy.